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Background: Despite progress in reducing cigarette smoking in the general U.S. population, smoking rates, cancer
morbidity and related heart disease remain strikingly high among the poor and underserved. Homeless individuals’
cigarette smoking rate remains an alarming 70 % or greater, and this population is generally untreated with
smoking cessation interventions. Furthermore, the majority of homeless smokers also abuse alcohol and other
drugs, which makes quitting more difficult and magnifies the health consequences of tobacco use.
Methods/Design: Participants will be randomized to one of three groups, including (1) an integrated intensive
smoking plus alcohol intervention using cognitive behavioral therapy (CBT), (2) intensive smoking intervention
using CBT or (3) usual care (i.e., brief smoking cessation and brief alcohol counseling). All participants will receive
12-week treatment with a nicotine patch plus nicotine gum or lozenge. Counseling will include weekly individual
sessions for 3 months, followed by monthly booster group sessions for 3 months. The primary smoking outcome is
cotinine-verified 7-day smoking abstinence at follow-up week 52, and the primary alcohol outcome will be
breathalyzer-verified 90-day alcohol abstinence at week 52.
Discussion: This study protocol describes the design of the first community-based controlled trial (n = 645)
designed to examine the efficacy of integrating alcohol abuse treatment with smoking cessation among homeless
smokers. To further address the gap in effectiveness of evidence-based smoking cessation interventions in the
homeless population, we are conducting a renewed smoking cessation clinical trial called Power to Quit among
smokers experiencing homelessness.
Trial registration: ClinicalTrials.gov Identifier: NCT01932996. Date of registration: 20 November 2014.Background
Despite progress in reducing cigarette smoking in the gen-
eral U.S. population, smoking rates and related morbidity
remain strikingly high among the poor and underserved.
Specifically, the cigarette smoking rate remains an alarming
70 % or greater [1, 2] among the approximately 3 million
homeless people in the United States the annual smoking
rate among the homeless population is 70 % [3, 4]. This* Correspondence: oojofati@umn.edu
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smoking cessation interventions, but, in addition, tobacco-
related illnesses such as lung and heart disease are fast be-
coming the most common cause of death in the homeless
population, especially among individuals between 45 and
64 years of age [5, 6]. Given that smokers are at increased
risk for tobacco-related diseases [7], such as respiratory
diseases (e.g., chronic obstructive pulmonary disease and
upper respiratory infection), cardiovascular diseases (e.g.,
stroke, hypertension and peripheral vascular diseases) and
cancers (e.g., lung, head and neck, stomach, bladder and
colon), continued high smoking rates in homeless popula-
tions carry serious health consequences [8–11]. Further-
more, the health consequences of smoking may be
particularly increased among homeless individuals becausele is distributed under the terms of the Creative Commons Attribution 4.0
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to health care, poor nutrition and comorbidities of
substance abuse, mental illness and other chronic diseases
[6, 9, 12–16]. Yet, a lack of evidence on how to assist home-
less smokers with quitting remains undiscovered, as smok-
ing cessation research usually excludes this population.
In addition to high prevalence of tobacco use in home-
less populations, the rates of drug and alcohol abuse are
increased in this population [6]. Research has confirmed
the strong association between cigarette smoking and al-
cohol use [17–20]. Whereas the overall cigarette smok-
ing rates in the United States have declined, smoking
rates remain significantly elevated among people with al-
coholism. The prevalence of cigarette smoking among
alcohol-dependent persons is nearly 80 %, more than
three times the smoking rate of the general population.
Cigarette smokers also drink alcohol more often and more
heavily than non-smokers [21–26]. Studies have shown
that the health consequences of chronic tobacco and alco-
hol use are synergistic [27, 28]. For instance, in one study
of 4928 people with alcoholism [29], high cancer mortality
was attributed solely to smoking. One potential enhance-
ment to smoking interventions for homeless smokers is to
provide concurrent alcohol treatment for those with heavy
alcohol use. In studies of concurrent smoking cessation
and substance use treatment, researchers have consistently
found that smoking abstinence is associated with reduc-
tions in substance use after treatment [30, 31]. Despite
ample evidence that pharmacotherapy and counseling are
effective for smoking cessation in the general population,
to date no one has identified effective methods for extend-
ing the benefits of these treatments or related interven-
tions to the homeless.
Despite high cigarette-smoking rates and disease burden
in homeless populations, smoking cessation programs
have been focused, for the most part, on non-homeless
persons. The exclusion of homeless smokers from smok-
ing cessation interventions may rest on the beliefs that
smokers in this population are difficult to recruit and re-
tain in clinical trials and that the population lacks interest
in cessation. Also, owing to the fact that homeless individ-
uals are faced with meeting basic survival needs such as
finding food and shelter, some may assume that smoking
cessation is not a priority for the homeless and that it
should not be a priority for health care providers. How-
ever, recent data do not support this assumption. In a sur-
vey of 236 homeless adults at 9 homeless service sites,
researchers found a smoking prevalence of 69 %, and of
these smokers, 72 % attempted to quit at least once and
37 % reported readiness to quit smoking within the next 6
months [5]. In the same study, the investigators found that
nicotine replacement therapy (NRT) alone or in combin-
ation with other treatments was the most preferred treat-
ment. Our research team [20] found that, compared withtheir non-homeless counterparts, homeless smokers
had made similar numbers of quit attempts in the
previous year and expressed similar levels of interest
in participating in a program to help them quit
smoking (7.4 for homeless vs. 7.9 for non-homeless
on a scale of 1–10) [32].
In our recently completed Power to Quit (PTQ) study
(N = 430) [32, 33] targeting homeless smokers, we found
cotinine-verified 7-day quit rates to be 9.3 % for motiv-
ational interviewing (MI) vs. 5.6 % for the control group
at 26 weeks. These quit rates are low when compared
with those in the general population, demonstrating the
challenge for a smoking intervention in homeless popu-
lations. A variety of factors may have contributed to low
quit rates in the study, including (1) high level of nicotine
dependence as indicated by mean 20 cigarettes per day
and 87 % of the participants smoking their first cigarette
within 30 minutes of awakening, (2) high rates of sub-
stance abuse and psychiatric comorbidities [18, 19],
(3) competing daily social needs and (4) need for more
cognitive behavioral strategies instead of MI, given the
high baseline motivation to quit (9+ on a 1–10 scale).
The low quit rates revealed in studies of alcohol-
dependent and homeless smokers, along with positive
outcomes in studies of combined NRT, suggest that a
more intensive intervention ought to be considered.
The primary aim of the present study is therefore to
evaluate the effects of an intensive smoking interven-
tion that integrates alcohol abuse treatment and smok-
ing cessation in a homeless population. We will use a
three-group randomized design to test the study hy-
potheses in a community-based setting. The three
study conditions are (1) integrated intensive smoking
intervention using cognitive behavioral therapy (CBT)
plus alcohol intervention (IntS+A), (2) an intensive
smoking (IS) intervention using CBT or (3) usual care
(UC; brief smoking cessation and brief alcohol coun-
seling, both based on U.S. Public Health Service
[USPHS] guidelines) [34, 35]. In addition, all partici-
pants will receive a 12-week treatment with a combin-
ation of nicotine patch plus gum or lozenge.
Methods/Design
Overview of study design
Figure 1 gives an overview of the study. The primary
aim of the current PTQ-2 study is to evaluate the effects
of an intensive smoking intervention that integrates al-
cohol abuse treatment in a homeless population. Eligibil-
ity screening and all subsequent study visits will take
place at homeless shelters to make participation con-
venient for participants. Once eligibility is determined,
participants will complete a baseline assessment. In-
formed consent will be obtained from each participant
before any study procedures are initiated. Participants
Fig. 1 Flowchart of the Enhancing Smoking Cessation in the Homeless Population study. CBT cognitive behavioral therapy, NRT nicotine
replacement therapy, LTFU long-term follow-up, SC+A combined smoking cessation and alcohol
Ojo-Fati et al. Trials  (2015) 16:385 Page 3 of 12will be randomized to one of three groups: UC (NRT +
brief, one-time counseling for both alcohol and smoking
cessation), IS (NRT+CBT for smoking cessation) plus
brief alcohol counseling, and IntS+A (NRT+CBT for
both alcohol and smoking cessation). All three groups
will receive biweekly supplies of NRT (21-mg patch +
gum and/or lozenge) for a total of 12 weeks beginning at
week 4. Participants in all three groups are instructed on
the correct daily use of both the patch and gum/lozenge
and are encouraged to contact study staff with anyconcerns or issues related to NRT use. The UC group
will receive a brief, one-time counseling session (ap-
proximately 20 minutes) of standard advice for both al-
cohol and smoking cessation at their baseline visit,
which is based on the USPHS guidelines [34].
Counseling using CBT follows a protocol used in a re-
cent study of alcohol-dependent smokers [36–38]. Dur-
ing the first 3 weeks after enrollment, CBT counseling
sessions will focus on the participants’ preparation for
their quit date, on which they will receive the NRT.
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hol counseling plus 12 weekly CBT counseling sessions,
starting at their baseline visit, that are 20–30 minutes in
length. Last, participants randomized to the IntS+A
group will receive 12 weekly CBT counseling sessions
beginning at their baseline visit, each of which are ap-
proximately 50–60 minutes in length. The study design
does not include a placebo arm, owing to ethical con-
cerns. The primary smoking outcome is cotinine-verified
7-day smoking abstinence at follow-up week 52, and the
primary alcohol outcome will be breathalyzer-verified
90-day alcohol abstinence at follow-up week 52. The
secondary smoking outcome will be prolonged smoking
abstinence at weeks 12, 26 and 52 with CO verification
at weeks 12 and 26. CO is used for verification at these
times because cotinine verification is not useful in the
context of NRT. The secondary alcohol outcome will be
self-reported continuous alcohol abstinence for 30 days
at weeks 12 and 26 and for 90 days at week 52.Study setting
All study procedures, including eligibility, enrollment,
assessments and counseling sessions, will be administered
at the homeless shelters. Participants will be recruited
from a variety of homeless emergency shelters and transi-
tional housing units in the Minneapolis-St. Paul (Twin
Cities), MN, USA, area. Currently, participants for the
PTQ-2 pilot are being recruited from the Dorothy Day
Center in St. Paul, MN, USA, with expansion to other sites
planned for the initiation of the main study (see Table 1).
Strategies for recruiting participants begin with establishing
connections with potential shelter sites and conducting in-
formational sessions with shelter staff. Recruitment then
progresses to include promotional flyer distribution, an-
nouncement of the PTQ-2 study at peak use times at the
shelter and word of mouth from current participants and
study staff to shelter users. The study team will include the
project coordinator, three full-time research counselors
with a minimum of a master’s degree plus at least 1 year of
experience in CBT for addiction treatment, two volun-
teers who will assist the community mobilizer (out-
reach workers) in recruiting and enrolling participants,
and a community mobilizer who has a past history of
homelessness and working with the homeless population.
The volunteers will also assist the team in administering
the eligibility surveys to the willing participants. All re-
search counselors will receive extensive CBT training
from the licensed clinical psychologist on the research
team before the commencement of the project. The pro-
ject office will serve as the base location for the research
team and will be located at a facility nearby to the home-
less shelter. The project coordinator will review the sur-
veys before enrolling the eligible participants.During enrollment, participants will be given the
Health Insurance Portability and Accountability Act of
1996 (commonly known as “HIPAA”) and consent forms
to read carefully and sign if they wish to be enrolled in
the trial. The staff will ensure that the participants have
full understanding of the content of the forms by asking
open-ended questions before they sign the documents.
Baseline surveys, CO and breathalyzer tests, sputum col-
lection and randomization will be administered by the
community mobilizers in the cafeteria within the shelter,
away from the shelter officers and other participants to
maintain confidentiality. On the basis of the experience
in the first PTQ study, we believe that this entire process
should last approximately 90 minutes. The counselors
will then take the enrolled participants to a private office
reserved by the shelter staff for a one-to-one counseling
session to establish a counselor–participant relationship
and reassure participants of the privacy and confidential-
ity of their participation. Each counseling session will
take between 30 and 60 minutes, depending on to which
randomized arm the participant is allocated. To stay or-
ganized, staff will create a separate file for each enrolled
participant. Each file will consist mainly of the coun-
selors’ materials and other records pertaining to the par-
ticipants. Reminder calls will be made and appointment
reminder slips will be given to participants. An adverse
event worksheet will also be completed by the staff when
a participant cannot make the appointment because of
an illness or injury. This system was effective in the last
PTQ study and contributed to the 75 % follow-up and
retention rate.
Participants
A total of 645 participants will be enrolled in the study
(Fig. 2). Final follow-up for each participant will be at
week 52 of their participation in the trial. Participants will
be randomized into one of three groups: UC (n = 215), IS
(n = 215) or IntS+A (n = 215). Eligibility criteria are
(Table 2) currently homeless [21], current daily cigarette
smoker, aged 18 years or older, willing to use NRT
(nicotine patch and gum or lozenge) for 12 weeks, will-
ing to participate in counseling sessions for 12 weeks
and willing to complete 16 total appointments (12 weekly
counseling visits, 3 monthly group counseling visits and 1
retention visit) over the 52-week study period. The deter-
mination of participants’ homelessness will be based on
the Stewart B. McKinney Act, passed by the U.S. Congress
in 1987, in which homelessness is defined as “any individ-
ual who lacks a fixed, regular and adequate nighttime resi-
dence” or “one whose primary nighttime residence is a
supervised publicly or privately operated shelter designed
to provide temporary living accommodations, transitional
housing, or other supportive housing program or a public
or private place not meant for human habitation (e.g., on











The DDC is run by the umbrella
organization Catholic Charities of
Minnesota. The population that uses DDC
is mostly male and mostly single; 15 % of
the guests are over 55 years of age.
Emergency shelter, space for 250 90 2688/2014
Transitional housing, 42-bed women’s
shelter
Meals (breakfast, lunch, dinner)
Food shelf
Medical and mental health care
Housing and employment advocacy
Counseling support




OSS offers faith-based activities and other
services. In the emergency shelter pro-
gram, 85 % of the individuals are male,
46 % are African American and 88 %
have a high school diploma or graduate
equivalency degree (GED) or more. In the
transitional housing program, there are
15 men, 16 women and 9 children.
Emergency shelter, 40 beds per night 34 650/2013
Transitional housing, 40 men, women and
children
Two meals daily (lunch, dinner)
Bathroom/shower facilities
Case management services
Permanent supportive housing services
Union Gospel
Mission
The Union Gospel Mission site is a faith-
based site that concurrently runs a short-
term emergency relief program alongside
a transitional housing program and an
intense alcohol and drug treatment facility.
Emergency shelter, space for 120 persons 32 2015
Transitional housing, 145 rooms
Alcohol drug treatment center, 75 men
24-h service desk
Intensive treatment programs







PSP is a short-term transitional housing
center that is geared to helping families
find housing. The program’s stated goal is
to help children by giving them direct care
or by assisting their parents to gain the
skills that will keep their families off the
streets. The program serves women and
children. About 60 % of those PSP serves
are under 18 years of age, and 32 % of the
total population is under age 5 years.
Three meals daily 39 1,286/2013
Medical clinic open 5 days/week
Mental health and chemical dependency services,
employment assistance, literacy, early childhood
development and legal aid programs
Guest access to voice mail, e-mail and in-house
library
24-h front desk service supplying diapers, formula,
warm clothing and other basic needs
Training programs in life skills, culinary arts,
facilities training and workforce development
Counseling services
Family advocates to ensure families get
connected with the resources and services they need
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biles)” [4, 9, 21]. Participants will also be considered to be
homeless if they have been residing with family or friends
for a period of 3 months or less. Current smoking isdefined as smoking at least one cigarette per day in the
previous 7 days and having smoked at least 100 cigarettes
in the participant’s lifetime. To confirm their smoking sta-
tus, participants will be asked to take an exhaled CO test
Fig. 2 Overview of study procedures. CBT cognitive behavioral therapy, NRT nicotine replacement therapy
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ommendations of the Society for Research on Nicotine
and Tobacco [22–24].
Additional eligibility criteria include willing to use
NRT, having lived in the Twin Cities area for at least 3
months and planning to stay in the Twin Cities area for
the next 12 months. Additionally, women are excluded if
they are currently pregnant or are not willing to use
birth control for the duration of the study. Exclusion cri-
teria include use of smoking cessation medications or in-
terventions in the previous 30 days, unstable medical
illness that requires immediate medical care, current his-
tory of alcohol dependence, previous severe alcoholwithdrawal symptoms and/or events, Alcohol Use Disor-
ders Identification Test score less than 7, pregnancy and
cognitive impairment.
A community advisory board (CAB) with 10 members
will be convened before the launch of the PTQ-2 pilot.
The plan is for the CAB to meet two or three times each
year during the 5-year project. The CAB, which is an
important part of the study, is composed of directors
and managers from various shelters and agencies through-
out the Twin Cities area that serve homeless individuals.
The CAB plays a crucial role in providing insight into the
challenges homeless individuals faced, as well as barriers
related to study participation and retention. CAB
Table 2 Eligibility criteria for participants
Inclusion criteria Exclusion criteria
• Currently homelessa • Participation in previous PTQ study
• Smoke ≥1 cigarette/day in previous 7 days • Use of smoking cessation medications or interventions in previous 30 days
• Smoked ≥100 cigarettes in lifetime • Unstable medical illness that requires immediate medical care
• AUDIT score ≥7 • AUDIT score <7
• Aged 18 years or older • Pregnancy or other NRT contraindications
• Willing to attend study sessions and follow
other study protocols
• Current history, or in past 6 months, of psychotic disorder or major depressive disorders and not
stable on treatment for past 3 monthsb
• Cognitive impairmentc
AUDIT Alcohol Use Disorders Identification Test, NRT nicotine replacement therapy, PTQ Power to Quit
aWe will use the definition in the Stewart B. McKinney Act, passed by the U.S. Congress in 1987
bThis determination will be made by the study psychiatrist
cWe will use the Mini Mental State Examination to make this determination
Ojo-Fati et al. Trials  (2015) 16:385 Page 7 of 12members also contribute valuable insight that is helpful in
aiding study activities with this vulnerable population.
Randomization process
After final eligibility is confirmed, all participants who
sign the informed consent document will be randomized
into one of three groups: (1) IntS+A, (2) IS or (3) UC. A
block randomization with three or six random blocks
will be used to improve balance. The statistician devel-
oped the randomization scheme for the study. In this
scheme, each participant is randomized on-site by study
staff using the established protocol during the enrollment
visit. All participants will receive 12-week treatment with
nicotine patch plus nicotine gum and/or lozenge.
Counselor training
Our therapists do not come to the trial as trained psy-
chotherapists, but they are provided with extensive CBT
training before engaging with participants. Although our
counselors are trained in CBT, they are not trained psy-
chotherapists. Counselors meet individually or in groups
of two for intensive training with the counseling super-
visor for a minimum of 40 hours before being assigned
participants. In addition, fidelity monitoring and supervi-
sion are provided each week in a group format with indi-
vidual supervision provided on an as-needed basis.
Intervention components
Integrated intensive smoking intervention using cognitive
behavioral therapy plus alcohol intervention
Participants in the IntS+A group will receive separate al-
cohol and smoking counseling during each session. Each
session will be broken down into two 30-minute seg-
ments of distinct alcohol counseling and smoking inter-
vention. Participants will receive weekly counseling for
the first 3 months, followed by monthly group sessions
for the next 3 months. After the initial session, the
counselor will allow the participant to decide whether to
address alcohol or smoking first, and each subsequentsession will alternate which topic begins the session. The
content covered in the smoking module in the IntS+A
condition is identical to that in the IS condition. The
CBT model employed to address both smoking and alcohol
follows the antecedent–behavior–consequences) model and
places equal weight on identifying and changing thought
patterns as behavior modification. Counselors will encour-
age participants to identify their antecedent thoughts and
situational factors (i.e., triggers and cues) contributing to
their smoking and alcohol use and to examine the conse-
quences of their use. The alcohol counseling will be distinct
from smoking counseling, and in it similarities between
quitting smoking and stopping alcohol and drug use will
not be emphasized. This is based on findings from a study
[39] in which researchers reported that emphasizing these
similarities led to worse alcohol outcomes compared with
concurrent treatment that did not emphasize the similar-
ities. The alcohol intervention manual is based on the Na-
tional Institute on Drug Abuse manual for CBT for drug
abuse [38, 39]. The treatment manuals and participant
handbooks were developed using both the alcohol treat-
ment protocol used by Cooney and colleagues [38] and a
CBT approach [38, 40]. Both manuals were modified to ad-
dress the needs of this trial. The key alcohol interventions
will include self-monitoring of triggers, cravings and
urges; and functional analysis of drinking behavior
(i.e., antecedents, behavior and consequences).
Intensive smoking intervention using CBT
Participants in the intensive smoking intervention arm
will receive 12 weeks of NRT plus weekly individual
smoking cessation counseling sessions for the first 3
months, followed by monthly group sessions for the next
3 months. In addition, they will receive the brief alcohol
counseling also provided to the UC participants. CBT
strategies will be employed to identify and address
smoking triggers and to employ urge reduction strat-
egies, including delay, escape, avoid, distract and substi-
tute. The key intervention strategies will also include
Ojo-Fati et al. Trials  (2015) 16:385 Page 8 of 12introducing self-monitoring of smoking behavior, com-
pleting a functional analysis of smoking using a smoking
“wrap sheet,” developing a specific quit plan, enlisting al-
lies and relapse prevention. The participants will be
asked to quit after their fourth counseling session [41].
Usual care (brief smoking cessation and brief alcohol
counseling, both based on USPHS guidelines)
In the UC condition, participants will receive NRT as de-
scribed above for the IS intervention and brief (20 min),
one-time counseling for smoking and alcohol cessation.
The smoking cessation counseling will be based on the
“five A’s” model (ask, advise, assess, assist, arrange) recom-
mended in the USPHS clinical practice guidelines [34].
Consistent with these guidelines, counselors will carry out
the following procedures: (1) congratulate the participant
on enrolling in the study, (2) describe the harms related to
smoking and the benefits of quitting, (3) advise the partici-
pant to quit immediately, (4) assist participants to set a
quit date, (5) encourage participants to tell friends and
family about their quitting and (6) describe potential re-
lapse situations and other barriers to quitting. The brief al-
cohol counseling will follow USPHS guidelines [42] and
includes elements such as (1) presenting screening results,
(2) identifying risks, (3) discussing consequences, (4) soli-
citing commitment, (5) identifying goals and (6) giving ad-
vice and encouragement. At the end of the session,
participants interested in additional smoking or alcohol
interventions will be referred to local and national treat-
ment programs. We will measure participants’ engage-
ment in smoking cessation or alcohol programs outside
the study as potential moderators of intervention effects.
Study procedures
Individual session 1
The first session will begin at baseline after enrollment.
This visit will last up to 90 minutes, whereas most other
visits will last 30–60 minutes, depending on to which group
the participant is assigned. Ground rules will be established
at the first counseling session; participants will also be in-
formed that each counseling session will be audio-recorded
before the commencement of the session. CO testing and
an alcohol breathalyzer test will be conducted at all individ-
ual sessions. The UC group will receive a brief, one-time
advice session on smoking cessation and alcohol use. Par-
ticipants will receive a $20 gift card, tote bag and two bus
tokens at this session as compensation for their time.
Individual sessions 2–12
Session counseling procedures for the IS and IntS+A
conditions will follow the same format as the first ses-
sion. At all sessions, a survey will be administered by the
community mobilizer before the counseling session be-
gins. Additionally, participants will be asked about theirsmoking history and/or drinking patterns, as well as
craving, depending on the CBT arm to which they were
randomized. Task assignments, within-session role play-
ing, coping skills training, identification of cognitive and
environmental antecedents, behavioral choices and con-
sequences, and both past and future high-risk situations
will be carried out during the CBT counseling sessions.
A quit date will be set in the smoking arm at week 4.
NRT (nicotine patch plus gum or lozenge) will also be
carried out for 12 weeks starting at week 4. The esti-
mated session durations are 30 minutes for the IS group
and 60 minutes for the IntS+A arm.
Group sessions 17–25
After the week 16 survey, participants in the CBT groups
will be asked to return for booster group sessions for 3
months. Reminder calls will be made during the week to
each participant. Participants will be asked to complete
the weekly survey at their arrival. They will be encour-
aged to discuss their abstinence status and about the
day-to-day challenges they encounter. The research
counselors will ensure that the environment is comfort-
able for the participants and conducive to their express-
ing themselves. Procedures for the group will follow the
CBT format covered during the individual sessions. All
group counseling sessions will be cofacilitated by trained
study and homeless shelter staff. Participants will receive
a $10 gift card and two bus tokens for as compensation
for their time. The estimated duration of the sessions is
30–60 minutes.
Weeks 26 and 52 follow-up
Participants will be asked to return at 6 months and 12
months postbaseline to participate in an outcome survey
and cotinine analysis to verify abstinence status. After
collection of samples and assessment, participants will
be asked about the study program and how to improve
it. Participants will receive $50 for participation at week
26 and $75 for week 52. Each visit will take approxi-
mately 60–90 minutes.
Outcomes
The primary smoking outcome is cotinine-verified 7-day
smoking abstinence at follow-up week 52, and the pri-
mary alcohol outcome will be breathalyzer-verified 90-
day alcohol abstinence at week 52. Exploratory aims are
to evaluate (1) how smoking cessation or reduction re-
lates to psychosocial factors such as levels of depression,
hopelessness and perceived stress at weeks 12, 26 and 52
of follow-up; (2) how alcohol abstinence or reduction re-
lates to psychosocial factors such as levels of depression,
hopelessness and perceived stress at 12, 26 and 52 weeks
of follow-up; (3) how treatment outcomes relate to history
of other substance abuse; (4) how treatment outcomes
Ojo-Fati et al. Trials  (2015) 16:385 Page 9 of 12relate to opportunities for employment and housing, as
well as overall health and well-being; and (5) participants’
perceptions of the acceptability and usefulness of compo-
nents of the various interventions. Additional aims include
identifying potential impacts on intervention efficacy of
psychosocial factors such as depression, hopelessness and
perceived stress; other substance abuse; changes in em-
ployment and housing; and overall health.
Participant incentives
Participants will be compensated with non-monetary in-
centives such as tote bags, bus tokens, stress balls, pens
and water bottles after taking the eligibility survey. At
enrollment, each participant will receive a $20 debit card
serviceable at any automated teller machine within the
United States, in addition to other small gift items, such
as playing cards, $5 Subway gift cards, bus tokens and
tote bags. Participants will receive $50 for participation
at week 26 and $75 for week 52. For all other visits com-
pleted, participants will receive monetary incentives of
$10. Participating shelters will also be compensated up
to $1000/year for their assistance with recruitment and
retention. Shelters will receive separate payments for
their therapists who participate in training ($25/h) and
cofacilitate the group counseling sessions ($50/h).
Data management
Data management for this project will encompass data
entry, data cleaning, identifying and tagging any cross-
overs and conversion into proper format for data ana-
lysis and recoding. REDCap (Research Electronic Data
Capture; http://project-redcap.org/), a secure web appli-
cation for building and managing online surveys and da-
tabases, will be used for design, implementation and
maintenance of the database. In addition, a computer-
based tracking system will be developed to follow each
patient and to prompt the staff regarding the upcoming
data collection point. Data collection points for each
subject will be calculated from his or her initial date of
contact. Before data collection, the study protocol was
approved and monitored by the University of Minneso-
ta’s Institutional Review Board.
Statistical analyses and sample size and power
calculations
For this study, 645 participants will be randomized at
baseline to test the main effects of smoking and alcohol
interventions for the primary smoking outcome (cotin-
ine-verified 7-day smoking abstinence at week 52 follow-
up) and alcohol outcome (breathalyzer-verified continu-
ous alcohol abstinence for 90 days at week 52 follow-
up). The study is powered to test the primary hypotheses
using χ2 tests and the secondary hypothesis using Fish-
er’s exact test. Assuming a two-sided χ2 test with a typeI error rate of 0.025 for each of two primary outcomes,
smoking abstinence rates of 18 % in the IntS+A group
versus 8 % in the IS group and 4 % in the UC group, a
sample size of 215 participants in the IntS+A group and
430 participants in the IS and UC combined group will
achieve a power of 80 %. With 645 participants and a
type I error rate of 0.025, we have greater than 90 %
power for the primary alcohol hypothesis, assuming 90-
day alcohol abstinence rates of 32 % vs. 10 % for the
IntS+A group versus the IS intervention or UC groups .
Assuming a two-sided Fisher’s exact test with a type I
error rate of 0.05 for the secondary outcome of smoking
abstinence rate of 12 % in the IntS group versus 4 % in
the UC group, a sample size of 215 participants per
group will achieve a power of 82 %. Our sample size cal-
culation was based on the analysis that classified those
lost to follow-up as smokers or drinkers and therefore
has accounted for up to a 25 % attrition rate observed in
the prior Power to Quit (PTQ) study [32, 33].
Basis for sample size
We based our estimates for the main outcomes on data
from our previous PTQ study among homeless smokers,
as well as from the available literature [38, 43]. In the
PTQ study, 7-day abstinence rates at week 26 were 9.3 %
for the MI+NRTcondition and 5.1 % for the control group.
In another study [43] of alcohol-dependent smokers, our
research team reported 7-day abstinence rates at 6 months
as 9.1 % and 2.2 % for an intensive smoking intervention
(three counseling sessions + NRT) and brief advice, re-
spectively. We therefore projected the smoking abstinence
rates as 4 % for the UC condition and 12 % for the IS con-
dition. Our PTQ study also showed that the smoking ab-
stinence rate for those who quit drinking during the study
was nearly double that for drinkers, despite not having an
alcohol intervention. We conservatively projected the
smoking abstinence rate for the IntS+A condition as 18 %.
We based the projection for the alcohol abstinence rates
on a study [38] in which our research team found 90-day
alcohol abstinence rates of 32–43 % at 12 months among
alcohol-dependent smokers.
Data analysis
Before initiating outcome analyses of quantitative data,
we will examine distributions for all variables, with par-
ticular attention to variable ranges, missing values, skew-
ness and transforming variables when indicated
according to the criteria of Winer [44]. Using analysis of
variance (ANOVA) for continuous data and χ2 tests for
categorical data, we will examine group comparability at
baseline to determine whether randomization was success-
ful in creating equivalent groups with regard to demo-
graphic, process and important independent variables such
as education, income and literacy levels. These data will
Ojo-Fati et al. Trials  (2015) 16:385 Page 10 of 12help determine if there is a need to incorporate stratifying
variables or covariates into later analyses.
Analyses for primary hypotheses
The primary analysis will be based on an intention-to-
treat analysis; that is, participants will be analyzed re-
garding the treatment to which they were randomized.
The intervention effects for the primary outcomes of
week 52 biochemically verified 7-day abstinence from
cigarette smoking and week 52 ninety-day abstinence
from alcohol consumption will be tested using χ2 tests.
Any participants lost to follow-up will be classified as
treatment failures (i.e., smoker or drinker). Bonferroni
procedures will be used to control for experiment-wise
type I error rate. Abstinence rates and corresponding 95 %
confidence intervals will be estimated and summarized
using appropriate tabular and graphical methods.
In supportive analyses, we will examine baseline vari-
ables, including demographics (age, sex, income and
education), nicotine dependence, withdrawal symptoms,
motivation and confidence, self-efficacy, social support,
perceived stress and depressive symptoms, in terms of
their relationship to study outcomes. Analyses account-
ing for these measures will be conducted using multiple
logistic regression including intervention groups as con-
trolled factors. Thus, we will be able to assess whether
the main conclusions from the primary analysis are ro-
bust for the inclusion of these baseline variables. Fisher’s
exact test will be used to compare the biochemically
verified 7-day smoking abstinence rates at week 52
follow-up between the IS and UC participants. Support-
ive analysis will be conducted using multiple logistic re-
gression including the intervention group as a predictor,
adjusting baseline covariates to assess whether the result
from secondary analysis is robust for the inclusion of
baseline covariates.
Analyses for exploratory aims
To examine how smoking cessation, alcohol abstinence,
smoking reduction and alcohol reduction at follow-up
weeks 12, 26 and 52 relate to the psychosocial factors
(e.g., level of depression, hopelessness and perceived stress),
other substance abuse, opportunities for employment and
housing and overall health, separate repeated-measures
logistic regression analyses with generalized estimating
equations or linear mixed models that account for the
repeated-measures structure of the data will be used to
examine the associations between each individual psy-
chosocial predictor and smoking or alcohol outcomes
at follow-up weeks 12, 26 and 52. Interaction terms be-
tween these factors and intervention indicators will be
further tested in these models. In model validation, we
will use analytic and graphical techniques to check as-
sumptions of linearity, homoscedasticity, multivariatenormality and independence of residuals. Descriptive
statistics will be used to summarize data, and ANOVA
or χ2 tests will be used to examine participants’ percep-
tions of the acceptability and usefulness of components
of the various interventions.
Ethics
Ethical approval was received from the University of
Minnesota’s Human Research Protection Program (ap-
proval date: 30 July 2014; Institutional Review Board
code number: 1307 M39761; assurance of compliance
number FWA00000312 [Fairview Health Systems Re-
search FWA00000325, Gillette Children’s Specialty
Healthcare FWA00004003]). The trial is registered at
ClinicalTrials.gov (NCT01932996).
Discussion
This study protocol describes the design of the first
community-based controlled trial (N = 645) to examine
the efficacy of integrating alcohol abuse treatment with
smoking cessation as an intervention for homeless
smokers. The study has a three-arm randomized design
to test the effects of intensive smoking intervention (i.e.,
higher dose and duration than the previous PTQ), and
alcohol abuse treatment is integrated with smoking ces-
sation using CBT. The three study conditions are an in-
tegrated intensive smoking intervention using CBT in
addition to an alcohol intervention (IntS+A); an inten-
sive smoking intervention using CBT (IS); and usual care
comprising brief smoking cessation and brief alcohol
counseling, both based on USPHS guidelines (UC). In
addition, all participants will receive 12-week treatment
with a combination of nicotine patch plus gum or loz-
enge. As a strategy to integrate the proposed project
with existing programs at the shelters, all group counsel-
ing sessions will be cofacilitated by trained study home-
less shelter staff. The previous study (N = 430) targeting
homeless smokers, although adequately powered, was a
relatively low-intensity study that showed cotinine-
verified 7-day quit rates of 9.3 % for MI and 5.6 % for
brief advice at 26 weeks. The investigators also found
that quitting smoking was associated with reduced alco-
hol use. These smoking quit rates are low compared
with the general population, demonstrating the chal-
lenge in delivering tobacco interventions in this popula-
tion and the need for more research. Further, the two
study conditions (8.7 % vs. 17.4 %) did not reach signifi-
cance. The lack of a significant difference in treatment
effect size at 26 weeks was attributed to the short duration
of the intervention. Therefore, in the present study, we
will examine the feasibility of enrolling and retaining a
group of homeless smokers in a 12-week smoking cessa-
tion program that combines individual counseling based
on CBT principles with pharmacotherapy (nicotine patch
Ojo-Fati et al. Trials  (2015) 16:385 Page 11 of 12and gum or lozenge) at week 52. The rationale for using
the CBT intervention rather than the MI intervention is
that baseline data showed that participants were already
highly motivated to quit smoking, as evidenced by the
75 % retention rate at the week 26 final visit [32], and
that they could therefore benefit from CBT strategies.
The designing of this study includes more intense inter-
ventions that include a higher dose of pharmacotherapy
(nicotine patch combined with nicotine gum or lozenge
for 12 weeks), an increased number of counseling sessions
weekly for 3 months, an increased duration of individual
sessions from 15–30 minutes to 60 minutes and use of
CBT to provide more cognitively based strategies in the
counseling sessions. Many of the challenges researchers
faced in the previous clinical trial, such as those seen when
recruiting, retaining and intervening with a homeless
population, were adjusted for in the design of this study.
Challenges included high migration within the region as
well as between shelters within the Twin Cities area, com-
peting needs that made it difficult to keep appointments,
and limited forms of available communication. The study
was designed with minimal exclusion criteria so that the
external validity of the results would be enhanced. Under-
standing the effectiveness of smoking cessation and alco-
hol abuse treatment for this underserved population will
assist researchers and health care providers in developing
and implementing smoking cessation interventions for
homeless and other vulnerable populations. The primary
smoking outcome is cotinine-verified 7-day smoking ab-
stinence at follow-up week 52, and the primary alcohol
outcome is breathalyzer-verified 90-day alcohol abstinence
at week 52.Trial status
The study is still in the first phase of participant recruit-
ment and enrollment.
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